Search research articles
Contact Us
Filters
Showing results (1-10 of 125) with videos related to
Page
of 13
Sort By:
Topics in Current Chemistry
|
April 23, 2013
Nemorubicin
Massimo Broggini
International Review of Cytology
|
September 5, 2002
Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients
Faina Vikhanskaya, Massimo Broggini
Cancers
|
January 24, 2019
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Giovanna Damia, Massimo Broggini
Cell Cycle (Georgetown, Tex.)
|
December 6, 2003
Cell cycle checkpoint proteins and cellular response to treatment by anticancer agents
Giovanna Damia, Massimo Broggini
Cancers
|
November 3, 2020
It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
Elisa Caiola, Massimo Broggini
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2004
Improving the selectivity of cancer treatments by interfering with cell response pathways
Giovanna Damia, Massimo Broggini
Frontiers in Oncology
|
January 22, 2026
Editorial: Innovative drug combinations for enhanced solid tumor treatment efficacy
Giovanna Damia, Massimo Broggini
Journal of Thoracic Disease
|
April 30, 2015
Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?-An update incorporating the DELTA trial data
Marina C Garassino, Massimo Broggini
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 29, 2020
LKB1ness Dictates ERK Inhibitors Response in NSCLC
Elisa Caiola, Massimo Broggini, Mirko Marabese
Cancer Treatment Reviews
|
February 26, 2013
Revisiting ovarian cancer preclinical models: implications for a better management of the disease
Francesca Ricci, Massimo Broggini, Giovanna Damia
Page
of 13
Search research articles
Search
Showing results (1-10 of 125) with videos related to
Sort By:
Page
of 13
Topics in Current Chemistry
|
April 23, 2013
Nemorubicin
Massimo Broggini
International Review of Cytology
|
September 5, 2002
Genetic alterations in ovarian cancer cells that might account for sensitivity to chemotherapy in patients
Faina Vikhanskaya, Massimo Broggini
Cancers
|
January 24, 2019
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Giovanna Damia, Massimo Broggini
Cell Cycle (Georgetown, Tex.)
|
December 6, 2003
Cell cycle checkpoint proteins and cellular response to treatment by anticancer agents
Giovanna Damia, Massimo Broggini
Cancers
|
November 3, 2020
It's Got Too Greedy. New Therapeutic Options for Metabolic[ally] Addicted NSCLC?
Elisa Caiola, Massimo Broggini
European Journal of Cancer (Oxford, England : 1990)
|
November 16, 2004
Improving the selectivity of cancer treatments by interfering with cell response pathways
Giovanna Damia, Massimo Broggini
Frontiers in Oncology
|
January 22, 2026
Editorial: Innovative drug combinations for enhanced solid tumor treatment efficacy
Giovanna Damia, Massimo Broggini
Journal of Thoracic Disease
|
April 30, 2015
Chemotherapy versus tyrosine kinase inhibitor in EGFR unselected population advanced non-small cell lung cancer still matter of debate?-An update incorporating the DELTA trial data
Marina C Garassino, Massimo Broggini
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 29, 2020
LKB1ness Dictates ERK Inhibitors Response in NSCLC
Elisa Caiola, Massimo Broggini, Mirko Marabese
Cancer Treatment Reviews
|
February 26, 2013
Revisiting ovarian cancer preclinical models: implications for a better management of the disease
Francesca Ricci, Massimo Broggini, Giovanna Damia
Page
of 13